CANTOS- RCT of canakinumab in the prevention of cardiovascular events in post-myocardial infarction patients with elevated hsCRP
Project Description
CANTOS- RCT of canakinumab in the prevention of cardiovascular events in post-myocardial infarction patients with elevated hsCRP” (Global -10067 / India -595)/ NEJM 2018.
Project Duration
2018 - Ongoing
Authors
-
Project Status
completed